UNSPSC 85891414: High dose rate (hdr) brachytherapy of bone marrow using palladium 103 (pd-103)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of bone marrow using palladium 103 (pd-103). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code D7109BZ

UNSPSC 85891414 High dose rate (HDR) brachytherapy of bone marrow using palladium 103 (Pd-103) is a Commodity code that shows no relevant recent state and local procurement activity. The single recent opportunity tagged to this code—Santa Clara County Health System's RFQ for temporary health professional staffing services across ancillary clinical categories including audiology, cardiology, diagnostic imaging, gastroenterology, ophthalmology, orthopedic, respiratory care, sterile processing, and therapy services—bears no relationship to the code's nominal scope of specialized oncologic brachytherapy procedures. The mismatch suggests either a coding error at the issuing body or a misalignment between the procurement taxonomy and the actual work being solicited.

Without additional opportunities in the recent-activity record, no geographic concentration, issuing-body pattern, or representative procurement trend can be characterized under this code. State and local procurement databases occasionally apply Commodity-level medical codes to general clinical staffing, purchasing, or infrastructure solicitations that do not match the specialized treatment modality the code describes. Firms pursuing work in oncologic brachytherapy or specialized bone marrow therapies should monitor the code directly or consult with individual health systems and cancer centers to identify relevant RFQs and RFPs, as this code appears to generate limited or misaligned solicitation activity in the state and local space.